Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.5M Sell
175,310
-93,552
-35% -$8.96M 0.02% 553
2026
Q2
$28.8M Sell
268,862
-78,881
-23% -$8.68M 0.04% 343
2026
Q1
$36.6M Sell
347,743
-1,844
-0.5% -$217K 0.06% 277
2025
Q4
$43.6M Buy
349,587
+42,366
+14% +$5.05M 0.07% 241
2025
Q3
$36.7M Buy
307,221
+197,287
+179% +$20.8M 0.06% 271
2025
Q2
$10.1M Buy
109,934
+36,105
+49% +$3.29M 0.02% 592
2025
Q1
$6.42M Sell
73,829
-1,365,455
-95% -$134M 0.01% 654
2024
Q4
$134M Sell
1,439,284
-25,743
-2% -$2.48M 0.25% 85
2024
Q3
$134M Buy
1,465,027
+86,885
+6% +$7.3M 0.25% 92
2024
Q2
$103M Buy
+1,378,142
New +$110M 0.2% 113

Other funds holding CRH

Aberdeen Group's CRH Position: Q3 2026 in Review

Aberdeen Group reduced its CRH (CRH) stake by 35% in Q3 2026, selling an estimated $8.96M and leaving 175,310 shares worth $14.5M. The position accounts for 0.02% of the portfolio, ranked #553.

Aberdeen Group first reported a position in CRH in Q2 2024 and has held it in 10 quarters since. The position peaked at $134M in Q3 2024. 444 funds tracked by Wall St. Rank hold CRH as of Q3 2026.

  • Aberdeen Group held 175,310 shares of CRH worth $14.5M as of Q3 2026.
  • Aberdeen Group sold 93,552 CRH shares in Q3 2026, an estimated $8.96M.
  • CRH made up 0.02% of Aberdeen Group's portfolio in Q3 2026, its #553 holding.
  • Aberdeen Group first reported a position in CRH in Q2 2024 and has held it in 10 quarters since.
  • Aberdeen Group's CRH position peaked at $134M in Q3 2024.
  • 444 funds tracked by Wall St. Rank held CRH as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.